These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85. Isolation and characterization of a human plasma protein with affinity for the lysine binding sites in plasminogen. Role in the regulation of fibrinolysis and identification as histidine-rich glycoprotein. Lijnen HR; Hoylaerts M; Collen D J Biol Chem; 1980 Nov; 255(21):10214-22. PubMed ID: 6448849 [No Abstract] [Full Text] [Related]
86. Maintaining the balance: the critical role of plasmin activity in orthopedic surgery injury response. Moore-Lotridge SN; Hajdu KS; Hou BQ; Gibson BHY; Schoenecker JG J Thromb Haemost; 2023 Oct; 21(10):2653-2665. PubMed ID: 37558131 [TBL] [Abstract][Full Text] [Related]
87. Potent, Selective, Allosteric Inhibition of Human Plasmin by Sulfated Non-Saccharide Glycosaminoglycan Mimetics. Afosah DK; Al-Horani RA; Sankaranarayanan NV; Desai UR J Med Chem; 2017 Jan; 60(2):641-657. PubMed ID: 27976897 [TBL] [Abstract][Full Text] [Related]
88. Screening for Methylated Poly(l-histidine) with Various Dimethylimidazolium/Methylimidazole/Imidazole Contents as DNA Carrier. Asayama S; Kumagai T; Kawakami H Pharmaceutics; 2015 Aug; 7(3):224-32. PubMed ID: 26308045 [TBL] [Abstract][Full Text] [Related]
89. STREPTOCOCCAL FIBRINOLYSIS: A PROTEOLYTIC REACTION DUE TO A SERUM ENZYME ACTIVATED BY STREPTOCOCCAL FIBRINOLYSIN. Christensen LR J Gen Physiol; 1945 Mar; 28(4):363-83. PubMed ID: 19873427 [TBL] [Abstract][Full Text] [Related]
90. Using antifibrinolytics to tackle neuroinflammation. Atsev S; Tomov N Neural Regen Res; 2020 Dec; 15(12):2203-2206. PubMed ID: 32594031 [TBL] [Abstract][Full Text] [Related]
91. Histidine-rich glycoprotein (HRGP): Pleiotropic and paradoxical effects on macrophage, tumor microenvironment, angiogenesis, and other physiological and pathological processes. Pan Y; Deng L; Wang H; He K; Xia Q Genes Dis; 2022 Mar; 9(2):381-392. PubMed ID: 35224154 [TBL] [Abstract][Full Text] [Related]
92. [Large scale molecular organization in particles of DNA-poly-L-histidine association]. Brini M; Bourgoin D C R Acad Hebd Seances Acad Sci D; 1976 Mar; 282(9):929-31. PubMed ID: 820481 [TBL] [Abstract][Full Text] [Related]
97. Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen. Wu JH; Diamond SL J Clin Invest; 1995 Jun; 95(6):2483-90. PubMed ID: 7769094 [TBL] [Abstract][Full Text] [Related]
98. Comparison of the effect of histidine-rich glycoprotein and 6-aminohexanoic acid on plasmin production and fibrinolysis in vitro. Horne MK; Goad JL; Merryman PK; Cullinane AM Thromb Res; 2000 Jul; 99(2):179-86. PubMed ID: 10946092 [TBL] [Abstract][Full Text] [Related]
99. Fibrinolysis--a review. Kane KK Ann Clin Lab Sci; 1984; 14(6):443-9. PubMed ID: 6239587 [TBL] [Abstract][Full Text] [Related]
100. [Inhibition by ethanol and acetaldehyde the plasmin activity and plasminogen activation induced by urokinase and streptokinase]. Roszkowska-Jakimiec W; Jurkowski J; Ostrowska H; Worowski K Rocz Akad Med Bialymst (1989); 1988-1989; 33-34():53-66. PubMed ID: 2979011 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]